Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis

J Infect Dis. 1994 Sep;170(3):713-6. doi: 10.1093/infdis/170.3.713.

Abstract

The use of the polymerase chain reaction (PCR) for assessing treatment response in tuberculosis was investigated. Serial sputum samples were analyzed from 10 Tanzanian patients treated for smear-positive pulmonary tuberculosis, including 4 who relapsed after initially successful treatment. A one-tube nested PCR with a colorimetric detection system was compared with microscopy and culture. Samples were found to be negative by microscopy before they were by PCR or culture, often remaining positive 1-2 months longer by PCR than by culture. For the 76 samples available for both culture and PCR, there was a 76% (58/76) agreement between the methods. Nine samples were negative by culture but positive by PCR; 7 were either negative (5) or equivocal (2) by PCR despite being positive by culture. Two of the 4 relapse cases were detected earlier by PCR than by culture. These results demonstrate that PCR is a promising method for assessing treatment response in pulmonary tuberculosis.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Base Sequence
  • Colorimetry / methods
  • DNA Primers
  • DNA, Bacterial / analysis
  • Drug Therapy, Combination
  • Humans
  • Microscopy / methods
  • Molecular Sequence Data
  • Mycobacterium tuberculosis / isolation & purification*
  • Polymerase Chain Reaction / methods*
  • Sputum / microbiology*
  • Tanzania
  • Tuberculosis, Pulmonary / drug therapy*

Substances

  • Antitubercular Agents
  • DNA Primers
  • DNA, Bacterial